Isavuconazole as an alternative for antifungal prophylaxis in patients with hematological malignancies: Is the signal sufficient to support clinical practice?
Transplant Infectious Disease · 2023
DOI: 10.1111/tid.14046 ↗Kurz gefasst
Editorial in der Zeitschrift Transplant Infectious Disease, 2023. Verfasst von Armelle Perez-Cortes Villalobos und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Microbiology and Infectious Diseases, Max Rady School of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada. Hauptthemen laut MEDLINE: Antifungal Agents, Hematologic Neoplasms. Die Arbeit nennt 20 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Medical Microbiology and Infectious Diseases, Max Rady School of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada.
- Section of Infectious Diseases, Department of Internal Medicine, Max Rady School of Medicine, The University of Manitoba, Winnipeg, Manitoba, Canada.
- Section of Haematology/Oncology, Department of Internal Medicine, Max Rady School of Medicine, The University of Manitoba, Winnipeg, Manitoba, Canada.
- Department of Medical Oncology and Haematology, CancerCare Manitoba, Winnipeg, Manitoba, Canada.
- Infection Control Services, CancerCare Manitoba, Winnipeg, Manitoba, Canada.
Zitieren
APA
Villalobos, A. P., & Bow, E. J. (2023). Isavuconazole as an alternative for antifungal prophylaxis in patients with hematological malignancies: Is the signal sufficient to support clinical practice?. Transplant Infectious Disease. https://doi.org/10.1111/tid.14046
Vancouver
Villalobos AP, Bow EJ. Isavuconazole as an alternative for antifungal prophylaxis in patients with hematological malignancies: Is the signal sufficient to support clinical practice?. Transplant Infectious Disease. 2023. doi:10.1111/tid.14046
BibTeX
@article{Villalobos2023,
author = {Villalobos, Armelle Perez-Cortes and Bow, Eric J},
title = {Isavuconazole as an alternative for antifungal prophylaxis in patients with hematological malignancies: Is the signal sufficient to support clinical practice?},
journal = {Transplant Infectious Disease},
year = {2023},
doi = {10.1111/tid.14046}
}
EUVIMED